BELLINI trial

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

BELLINI trial

Sep 27, 2024, 16:31 | Insight

Immunotherapy for aggressive breast cancer appears to be effective even without chemotherapy - The Netherlands Cancer Institute

The Netherlands Cancer Institute posted on LinkedIn: "Immunotherapy as a treatment for an aggressive form of…

Sep 20, 2024, 08:16 | Blog

Yakup Ergün: Nivolumab/Relatlimab or Nivolumab/Ipilimumab in TNBC

Yakup Ergün, Medical Oncologist at Antalya City Hospital, shared on X: "Neoadjuvant nivolumab/relatlimab or nivolumab/ipilimumab in…

Apr 18, 2024, 13:58 | Insight

Ben Derman: Should MRD negativity be accepted as a surrogate endpoint for clinical trials in myeloma

Ben Derman, Assistant Professor at the University of Chicago, shared on X/Twitter: "Should MRD negativity…

All: 3 Posts: 1 - 100